News Focus
News Focus
icon url

Jonjones325

12/04/16 11:25 AM

#81935 RE: A_Good_Day_2 #81934

He needs to say it's years away. He does not want to mislead investors, be accused of pumping especially with the recent lawsuit or make promises that can't be kept.

Also, in the Health and Well being interview he stated. not verbatim. yes it it years away. However, the FDA has many expedited processes in place where we could possibly qualify for. Go back and listen. Why bring this up at all if it wasn't a possibility.

Also, if the 7 patients were on the more mild side of Alz and did not deteriorate further. It would give some credence to his other statement of possibly being a prophylactic.
icon url

sokol

12/04/16 11:28 AM

#81936 RE: A_Good_Day_2 #81934

Yes, I agree. The Senate votes this week on the Cures Act. It should pass. If so, faster FDA approval of drugs to treat these rare diseases for young patient populations is expected. If AVXL 2-73 obtains any approval for any disease, the FDA will be able to rely on data in the clinical trial obtaining approval to approve use of the same drug for other diseases as well (Cures Act specifies that). In any event, a physician may write a prescription for off label use (Alzheimer's for example) of any drug that the FDA has approved for any use.